Login / Signup

The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study.

Magdalena ChmielińskaAnna Felis-GiemzaMarzena OlesińskaAgnieszka Paradowska-GoryckaDariusz Szukiewicz
Published in: Rheumatology international (2024)
The results of the study support the hypothesis that the effectiveness of biological treatment of axSpA is limited by changed microbiota and intestinal epithelial barrier dysfunction, as an increased risk of biological treatment failure was observed in patients who were older, had higher zonulin level, IBD and repeated courses of antibiotics due to frequent infections. Therefore, starting biological treatment should be followed by reducing intestinal permeability and regulating the disturbed gut microbiome.
Keyphrases
  • randomized controlled trial
  • endothelial cells
  • rheumatoid arthritis
  • physical activity
  • combination therapy
  • systemic lupus erythematosus
  • smoking cessation
  • replacement therapy